Valuation: Mega Lifesciences

Market Cap 34.44B 1.03B 895M 836M 767M 1.45B 98.17B 1.47B 9.85B 3.86B 48.96B 3.87B 3.78B 161B P/E 2026 *
14.8x
P/E 2027 * 13.9x
Enterprise Value 29.83B 892M 775M 724M 664M 1.25B 85.03B 1.27B 8.53B 3.34B 42.4B 3.35B 3.28B 140B EV / Sales 2026 *
2x
EV / Sales 2027 * 1.89x
Free-Float
38.61%
Yield 2026 *
4.46%
Yield 2027 * 4.77%
1 day+3.95%
1 week+5.33%
Current month+3.95%
1 month+4.64%
3 months+10.49%
6 months+6.76%
Current year+17.91%
1 week 36.5
Extreme 36.5
39.5
1 month 36.5
Extreme 36.5
39.5
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.4
Extreme 17.4
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Change 5-day change 1-year change 3-year change Capi.($)
+3.95%+5.33% - - 1.03B
-2.39%-6.36%+47.10%+149.66% 1T
-0.76%-4.34%+52.04%+49.09% 613B
-2.33%-4.60%+25.55%+64.44% 433B
+0.68%-1.14%+38.47%+33.36% 350B
-1.66%-3.13%+32.18%+39.79% 292B
-8.96%-10.77%+3.57%+5.50% 239B
-1.37%-7.41%-2.10%-43.67% 206B
-1.63%+0.69%+27.62%+64.23% 204B
+0.72%+0.48%+15.88%+73.64% 163B
Average -0.99%-3.88%+26.70%+48.45% 388.94B
Weighted average by Cap. -0.93%-4.34%+34.73%+70.96%

Financials

2026 *2027 *
Net sales 14.91B 446M 388M 362M 332M 627M 42.52B 637M 4.27B 1.67B 21.2B 1.68B 1.64B 69.94B 15.69B 469M 408M 381M 350M 659M 44.72B 671M 4.49B 1.76B 22.3B 1.76B 1.72B 73.56B
Net income 2.33B 69.73M 60.61M 56.58M 51.94M 97.94M 6.65B 99.65M 667M 261M 3.31B 262M 256M 10.93B 2.47B 73.94M 64.26M 60M 55.08M 104M 7.05B 106M 707M 277M 3.51B 278M 272M 11.59B
Net Debt -4.61B -138M -120M -112M -103M -194M -13.15B -197M -1.32B -517M -6.56B -518M -507M -21.62B -4.76B -142M -124M -116M -106M -200M -13.57B -203M -1.36B -533M -6.77B -535M -523M -22.32B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
03/08/26 THB 39.50 +3.95% 2,310,700
31/07/26 THB 38.00 +0.66% 462,100
30/07/26 THB 37.75 +0.67% 1,202,900
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
39.50THB
Average target price
41.71THB
Spread / Average Target
+5.61%

Quarterly revenue - Rate of surprise